04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
There continues to be new, complicated problems arising from the improper completion and use of off-...
Read More >
The National Labor Relations Board (NLRB) has ruled that a property owner lawfully may prohibit the ...
Read More >
When an alleged hazard exists and causes a person to be injured, then maybe a business might think a...
Read More >
On Tuesday, April 7, we issued an alert in connection with New York Governor Andrew M. Cuomo’s Exec...
Read More >
The rapid expansion of data security and privacy laws and regulations — both in the United States a...
Read More >
Seyfarth Synopsis: The SECURE Act—just signed into law late last week—includes probably the most c...
Read More >